ロード中...
Bortezomib in multiple myeloma and lymphoma: a systematic review and clinical practice guideline
QUESTIONS: 1. In patients with multiple myeloma, Waldenström macroglobulinemia, or lymphoma, what is the efficacy of bortezomib alone or in combination as measured by survival, quality of life, disease control (for example, time to progression), response duration, or response rate? 2. What is the to...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Multimed Inc.
2006
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3394599/ https://ncbi.nlm.nih.gov/pubmed/22792013 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|